Results 91 to 100 of about 1,343,260 (212)

Orexin receptor antagonists in the treatment of depression: A leading article summarising pre-clinical and clinical studies

open access: yes, 2022
The orexin (hypocretin) system comprises two neuropeptides (orexin-A and orexin-B) and two G-protein coupled receptors (the orexin type 1 and the orexin type 2 receptor).
Jones, Edward   +2 more
core   +1 more source

Locus coeruleus microstructural integrity and sleep disruption in the context of Alzheimer's disease pathology

open access: yesAlzheimer's &Dementia, Volume 22, Issue 11, November 2026.
Abstract INTRODUCTION The locus coeruleus (LC) is among the first sites of tau pathology in Alzheimer's disease (AD) and plays a key role in sleep–wake regulation. However, evidence linking LC integrity to objective sleep measures in the context of emerging AD pathology remains limited.
Maxime Van Egroo   +10 more
wiley   +1 more source

Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury-induced coma: orexin-A-mediated N-methyl-D-aspartate receptor subunit NR1 upregulation

open access: yesNeural Regeneration Research, 2016
Electrical stimulation of the median nerve is a noninvasive technique that facilitates awakening from coma. In rats with traumatic brain injury-induced coma, median nerve stimulation markedly enhances prefrontal cortex expression of orexin-A and its ...
Zhen Feng, Qing Du
doaj   +1 more source

Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model

open access: yesAnnals of Neurology, Volume 100, Issue 5, Page 1023-1027, November 2026.
Narcolepsy type 1 is characterized by cataplexy, for which current treatments targeting monoaminergic, histaminergic, and GABAergic pathways may be ineffective or poorly tolerated. We report the case of a 34‐year‐old man with narcolepsy type 1, intolerant to standard therapies, who experienced marked and sustained cataplexy reduction with morning ...
Francois Ricordeau   +8 more
wiley   +1 more source

Efficacy of High‐Frequency Transcranial Magnetic Stimulation Therapy for Depression With Insomnia Symptoms: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
It summarizes the key findings: improves sleep quality (SMD0.97) and depressive symptoms(SMD0.61) in depression‐related insomia ABSTRACT Background This meta‐analysis evaluated the efficacy of high‐frequency repetitive transcranial magnetic stimulation (HF‐rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC) in patients with comorbid ...
Wenqing Yang   +5 more
wiley   +1 more source

Hepatic branch vagus nerve plays a critical role in the recovery of post-ischemic glucose intolerance and mediates a neuroprotective effect by hypothalamic orexin-A.

open access: yesPLoS ONE, 2014
Orexin-A (a neuropeptide in the hypothalamus) plays an important role in many physiological functions, including the regulation of glucose metabolism.
Shinichi Harada   +3 more
doaj   +1 more source

Localization of orexin B and orexin-2 receptor in the rat epididymis

open access: yesActa Histochemica, 2018
The peptides orexin A (OXA) and orexin B (OXB) derived from the proteolytic cleavage of a common precursor molecule, prepro-orexin, were originally described in the rat hypothalamus. Successively, they have been found in many other brain regions as well as in peripheral organs of mammals and other less evolved animals.
Giovanna Liguori   +8 more
openaire   +4 more sources

Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in IP rats

open access: yes, 2016
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in IP ...
SYS Khoo (15829220)   +5 more
core  

Advances in Multidimensional Molecular Mechanisms of Epilepsy and Precision Therapy Strategies

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Epilepsy arises from a multidimensional network imbalance, integrating genetic, inflammatory, and metabolic disruptions. This complexity drives neuronal hyperexcitability and underpins therapeutic challenges. Our review highlights how emerging precision strategies, from targeted molecular therapies to neuromodulation, offer a transformative path toward
Yimin Han   +7 more
wiley   +1 more source

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

open access: yesThe American Journal on Addictions, Volume 35, Issue 6, Page 702-726, November 2026.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy